avsa

The Bio AI team invites you to a live demonstration tomorrow featuring BIOS, our newly developed AI Scientist. @SynBio1, a synthetic biologist formerly with Ginkgo Bioworks, will participate in live interactive research runs. Tune in to observe how BIOS serves to accelerate biomedical discovery.

RSVP below

Tomorrow, we are hosting a live demonstration of BIOS, our new AI Scientist. Synthetic biologist and ex-Ginkgo Bioworks expert @SynBio1 joins the Bio AI team for live interactive research runs. Tune in to see how BIOS accelerates biomedical discovery. RSVP below.

Percepta by @Cerebrum_DAO has successfully received IRB approval to move forward with human trials. This initiative involves a 6-month decentralized study that is randomized, double-blinded, and placebo-controlled. The trial framework features the integration of wearable data alongside neurocognitive assessments for processing speed, memory, and cognitive function. Additionally, the study will track P-tau 217, which is currently the leading blood-based biomarker for cognitive decline.

A New Perspective on the AI Scientist: Utilizing BIOS and Interactive Multi-Agent Workflows for Scientific Discovery

Our livestream broadcast begins in 2 HOURS with @AakaashMeduri, @lukasweidener, @paulkhls, @cl2pp, and the Bio AI team. We will focus on BIOS, our new AI Scientist developed to manage complex biomedical research tasks through the orchestration of specialized scientific subagents. Please register via the link below.

Empowering a Scientific Intelligence Economy through BIOS

When laboratories and research professionals engage with BIOS for intricate biomedical investigations, they operate on a pay-per-query basis. These inquiries are distributed to specific subagents, each possessing expertise in distinct domains or research functions. For every useful contribution provided during this process, these subagents are compensated directly through the x402 payments protocol.

Picture an ecosystem populated by hundreds of these specialized digital entities, covering fields ranging from drug interactions and rare diseases to computational chemistry and cancer genomics. A true Agents GDP is created as these units vie for dominance in their respective fields, earning revenue based on the quality of their output. Financial value flows directly to the intelligence that successfully produces results.

This dynamic establishes a powerful positive feedback loop. As subagents strive for best-in-class status, the network's overall intelligence deepens, attracting a higher volume of researchers to the platform. Consequently, the circulation of $BIO increases, boosting the system's total value. This growth incentivizes developers to construct additional subagents, starting the cycle anew.

Explore the links below to discover more and experience BIOS firsthand.

We are inviting all scientists and AI researchers to tune in TODAY for the livestream debut of BIOS. Distinguished as the #1 ranked system on global benchmarks, this new AI Scientist is built specifically for interactive biomedical research. The @BioAIDevs group will be on hand to discuss the model and conduct a live demo regarding the use of the BIOS interface for scientific R&D.

RSVP ↓

FolliCool Shampoo developed by @HairDAO_ has officially arrived on the Biofy platform. Based on community studies, this formula is designed to ensure your hair feels voluminous while maintaining a calm scalp. Make sure to utilize the code BIOFY10 at checkout to secure a 10% discount. As an added perk, you will receive a 5K BioXP bonus with every order. Access the link below to purchase your FolliCool.

Please join us this THURSDAY for a livestream to unveil a new agentic science product designed for researchers.

We will also share a major milestone from our AI for Science lab and dive into our open-source framework for building scientific agents.

What will you discover?

RSVP below ↓

"""
Invest, educate, implement.

Bio is developing infrastructures to enhance the transition of biomedical science into practical applications:

• Bio Protocol: finance research, foster communities, transition from lab to market
• BioAgents: AI-driven scientists identify effective solutions, their target demographics, and underlying reasons
• Biofy: a commercial framework that transforms research into tangible, market-ready products

Digital infrastructures for expedited scientific advancement.

Moving from laboratory to consumer at a significantly reduced cost and speed.

Delivering scientific innovations by 2026.
"""

12 Days of DeSci Yapping Winners (Dec 24) 🎄

The distribution of BioXP to our daily winners has been completed, and it will be applicable for the upcoming $SKIN sale scheduled for early January.

There are just 4 days remaining until the XP for DeSci yapping concludes.

If your username appears in the list below, please take a moment to check your wallet on the Bio App ↓

"""
NOW STREAMING!

We're excited to share the most recent updates on Biofy, the nearly sold-out Moon + Sol launches from @dermadao, and the upcoming sale of $SKIN.

Be part of the conversation:
"""

HOLI Post-TGE Metrics ⬇

Starting valuation: $500,000
Highest valuation: $5.2 million
Achieved multiple: approximately 10x under present market conditions
Cumulative volume: $290,000
Number of participants: over 400

Price approximately two hours later: leveled off around $3.5 million

In a landscape where investment capital is discerning, this demonstrates a strong level of confidence—not just in $HOLI, but in the broader DeSci sector.

HOLI has successfully achieved its minimum funding target!

→ Over 100K USDC has been pledged by more than 400 contributors
→ Only a few hours remain to take part
→ The sale concludes TODAY at 3 PM UTC

This is your final opportunity to contribute USDC & BioXP: https://app.bio.xyz/ipts/holi

"""
Only 24 Hours Remaining in the @Holi_Labs Bio Sale! 🏋️‍♀️🧠

Holi Labs, helmed by Olympic athlete and biomechanics specialists @DerHarting and @DGarcia7, operates out of their GymLab in Berlin, which boasts over 1,000 members. They meticulously assess training stimuli with the same level of precision used for biomarkers.

Participate in the sale here: https://t.co/0yTya88YyS

With more than 200 BDNF blood samples collected, they are investigating the impacts of cardiovascular exercise versus weight training on brain health and longevity.

The objectives include:
> Developing datasets for coaching applications, wearable technology, AI research, and clinical collaborations
> Laying the groundwork for next-generation products focused on brain health training
> Establishing a patent-ready method-of-use protocol

Explore Holi's roadmap below and see the founder debunk common fitness tracking misconceptions.
"""

We're currently broadcasting!

Join us as we engage in a conversation with @Holi_Labs regarding their comprehensive human trial that evaluates the effects of weight training versus cardio within the AI-powered GymLab located in Berlin.

Don't miss out:

Join us in just 2 HOURS for the Bio Open Lab featuring @bdnf_daniel from @Holi_Labs!

We will explore Holi's trial testing comparing Weights and Cardio within its AI-driven GymLab located in Berlin, and the implications this could have for the future of longevity.

The $HOLI sale is currently active and will conclude on Friday, December 19.